Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Preparation and characterization of transparent and conductive thin films of single-walled carbon nanotubes.

Maeda Y, Komoriya K, Sode K, Higo J, Nakamura T, Yamada M, Hasegawa T, Akasaka T, Saito T, Lu J, Nagase S.

Nanoscale. 2011 Apr;3(4):1904-9. doi: 10.1039/c0nr00940g. Epub 2011 Mar 15.

PMID:
21409241
2.

Safety and pharmacokinetics of urtoxazumab, a humanized monoclonal antibody, against Shiga-like toxin 2 in healthy adults and in pediatric patients infected with Shiga-like toxin-producing Escherichia coli.

López EL, Contrini MM, Glatstein E, González Ayala S, Santoro R, Allende D, Ezcurra G, Teplitz E, Koyama T, Matsumoto Y, Sato H, Sakai K, Hoshide S, Komoriya K, Morita T, Harning R, Brookman S.

Antimicrob Agents Chemother. 2010 Jan;54(1):239-43. doi: 10.1128/AAC.00343-09. Epub 2009 Oct 12.

3.

Characterization of the hepatic disposition of lanoteplase, a rationally designed variant of tissue plasminogen activator in rodents.

Komoriya K, Kato Y, Hayashi Y, Ohsuye K, Nishigaki R, Sugiyama Y.

Drug Metab Dispos. 2007 Mar;35(3):469-75. Epub 2006 Dec 18.

PMID:
17178768
4.

Fertility of bitches in which estrus was prevented with implantations of chlormadinone acetate for four years.

Hori T, Mukai K, Komoriya K, Shimizu N, Murakoshi M, Kawakami E, Tsutsui T.

J Vet Med Sci. 2005 Feb;67(2):151-6.

5.

Pharmacokinetics and pharmacodynamics of febuxostat (TMX-67), a non-purine selective inhibitor of xanthine oxidase/xanthine dehydrogenase (NPSIXO) in patients with gout and/or hyperuricemia.

Komoriya K, Hoshide S, Takeda K, Kobayashi H, Kubo J, Tsuchimoto M, Nakachi T, Yamanaka H, Kamatani N.

Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1119-22.

PMID:
15571213
6.

PK/PD and safety of a single dose of TMX-67 (febuxostat) in subjects with mild and moderate renal impairment.

Hoshide S, Takahashi Y, Ishikawa T, Kubo J, Tsuchimoto M, Komoriya K, Ohno I, Hosoya T.

Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1117-8.

PMID:
15571212
7.
8.

Preventive effects of sequential treatment with alendronate and 1 alpha-hydroxyvitamin D3 on bone mass and strength in ovariectomized rats.

Ito M, Azuma Y, Takagi H, Kamimura T, Komoriya K, Ohta T, Kawaguchi H.

Bone. 2003 Jul;33(1):90-9.

PMID:
12919703
9.

Type III secretion systems and bacterial flagella: insights into their function from structural similarities.

Blocker A, Komoriya K, Aizawa S.

Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3027-30. Epub 2003 Mar 11. Review.

10.

Helical structure of the needle of the type III secretion system of Shigella flexneri.

Cordes FS, Komoriya K, Larquet E, Yang S, Egelman EH, Blocker A, Lea SM.

J Biol Chem. 2003 May 9;278(19):17103-7. Epub 2003 Feb 5.

11.

Human neutrophils express messenger RNA of vitamin D receptor and respond to 1alpha,25-dihydroxyvitamin D3.

Takahashi K, Nakayama Y, Horiuchi H, Ohta T, Komoriya K, Ohmori H, Kamimura T.

Immunopharmacol Immunotoxicol. 2002 Aug;24(3):335-47.

PMID:
12375732
12.

Identification and localization of flagellins FlaA and FlaB3 within flagella of Methanococcus voltae.

Bardy SL, Mori T, Komoriya K, Aizawa S, Jarrell KF.

J Bacteriol. 2002 Oct;184(19):5223-33.

13.

Curative effect of combined treatment with alendronate and 1 alpha-hydroxyvitamin D3 on bone loss by ovariectomy in aged rats.

Ito M, Azuma Y, Takagi H, Komoriya K, Ohta T, Kawaguchi H.

Jpn J Pharmacol. 2002 Jul;89(3):255-66.

14.

The role of mast cells in the development of 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in rats.

Fukumoto Y, Kasai H, Takahashi H, Sugiyama H, Hase N, Kaneko H, Hamamura I, Aoki Y, Ota M, Kobayashi T, Katsuura Y, Kamimura T, Komoriya K.

Scand J Gastroenterol. 2002 May;37(5):555-60.

PMID:
12059057
15.

1 alpha,25-dihydroxyvitamin D3 suppresses interleukin-1beta-induced interleukin-8 production in human whole blood: an involvement of erythrocytes in the inhibition.

Takahashi K, Horiuchi H, Ohta T, Komoriya K, Ohmori H, Kamimura T.

Immunopharmacol Immunotoxicol. 2002 Feb;24(1):1-15.

PMID:
12022438
16.

Length of the flagellar hook and the capacity of the type III export apparatus.

Makishima S, Komoriya K, Yamaguchi S, Aizawa SI.

Science. 2001 Mar 23;291(5512):2411-3. Epub 2001 Feb 22.

17.

Effects of progesterone on the elevation of tail skin temperature in ovariectomized rats.

Kobayashi T, Tamura M, Hayashi M, Itano Y, Tanabe H, Katsuura Y, Ohta T, Komoriya K.

Jpn J Physiol. 2000 Dec;50(6):651-6.

PMID:
11173561
18.
19.

Effect of activated human protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats.

Aoki Y, Ota M, Katsuura Y, Komoriya K, Nakagaki T.

Arzneimittelforschung. 2000 Sep;50(9):809-15.

PMID:
11050697
20.

Effect of activated human protein C on experimental venous thrombosis induced by stasis with operative invasion in mice.

Aoki Y, Fukumoto Y, Inoue K, Katsuura Y, Komoriya K, Miyamoto S.

Arzneimittelforschung. 2000 Aug;50(8):695-9.

PMID:
10994152
21.

[Antiarrhythmic effects of pilsicainide hydrochloride and effects on cardiac function and ECG in dogs: comparison with disopyramide].

Hidaka T, Inoue T, Komoriya K, Hayashi Y, Inomata N.

Nihon Yakurigaku Zasshi. 2000 May;115(5):295-308. Japanese.

PMID:
10872181
22.

Effect of addition of Orvus ES paste to frozen canine semen extender on sperm acrosomes.

Tsutsui T, Hase M, Hori T, Komoriya K, Shimizu N, Nagakubo K, Kawakami E.

J Vet Med Sci. 2000 May;62(5):537-8.

23.

Allopurinol induces renal toxicity by impairing pyrimidine metabolism in mice.

Horiuchi H, Ota M, Nishimura S, Kaneko H, Kasahara Y, Ohta T, Komoriya K.

Life Sci. 2000 Apr 14;66(21):2051-70.

PMID:
10823345
24.

Elevation of tail skin temperature in ovariectomized rats in relation to menopausal hot flushes.

Kobayashi T, Tamura M, Hayashi M, Katsuura Y, Tanabe H, Ohta T, Komoriya K.

Am J Physiol Regul Integr Comp Physiol. 2000 Apr;278(4):R863-9.

25.

A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats.

Horiuchi H, Ota M, Kobayashi M, Kaneko H, Kasahara Y, Nishimura S, Kondo S, Komoriya K.

Res Commun Mol Pathol Pharmacol. 1999;104(3):307-19.

PMID:
10741381
26.

Nephrotoxic effects of allopurinol in dinitrofluorobenzene-sensitized mice: comparative studies on TEI-6720.

Horiuchi H, Ota M, Kaneko H, Kasahara Y, Ohta T, Komoriya K.

Res Commun Mol Pathol Pharmacol. 1999;104(3):293-305.

PMID:
10741380
27.
28.

Peroxisome proliferator-activated receptors are expressed in mouse bone marrow-derived mast cells.

Sugiyama H, Nonaka T, Kishimoto T, Komoriya K, Tsuji K, Nakahata T.

FEBS Lett. 2000 Feb 11;467(2-3):259-62.

29.

Flagellar proteins and type III-exported virulence factors are the predominant proteins secreted into the culture media of Salmonella typhimurium.

Komoriya K, Shibano N, Higano T, Azuma N, Yamaguchi S, Aizawa SI.

Mol Microbiol. 1999 Nov;34(4):767-79.

30.

Allopurinol increases ear swelling and mortality in a dinitrofluorobenzene-induced contact hypersensitivity mouse model.

Horiuchi H, Ota M, Kitahara S, Ohta T, Kiyoki M, Komoriya K.

Biol Pharm Bull. 1999 Aug;22(8):810-5.

PMID:
10480318
31.

Differential production of MCP-1 and cytokine-induced neutrophil chemoattractant in the ischemic brain after transient focal ischemia in rats.

Yamagami S, Tamura M, Hayashi M, Endo N, Tanabe H, Katsuura Y, Komoriya K.

J Leukoc Biol. 1999 Jun;65(6):744-9.

PMID:
10380894
32.

Regulation of RANTES and IL-8 production in normal human dermal fibroblasts by active vitamin D3 (tacalcitol).

Fukuoka M, Ogino Y, Sato H, Ohta T, Komoriya K.

Br J Pharmacol. 1998 Aug;124(7):1433-8.

33.
34.

RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol).

Fukuoka M, Ogino Y, Sato H, Ohta T, Komoriya K, Nishioka K, Katayama I.

Br J Dermatol. 1998 Jan;138(1):63-70.

PMID:
9536224
35.

Fc portion of intravenous immunoglobulin suppresses the induction of experimental allergic neuritis.

Miyagi F, Horiuchi H, Nagata I, Kitahara S, Kiyoki M, Komoriya K, Yuki N.

J Neuroimmunol. 1997 Sep;78(1-2):127-31.

PMID:
9307236
36.

Novel naphthalene derivatives as inhibitors of human immunoglobulin E antibody production.

Hasegawa M, Takenouchi K, Takahashi K, Takeuchi T, Komoriya K, Uejima Y, Kamimura T.

J Med Chem. 1997 Feb 14;40(4):395-407.

PMID:
9046329
37.

Effect of interleukin-10 on anti-CD40- and interleukin-4-induced immunoglobulin E production by human lymphocytes.

Uejima Y, Takahashi K, Komoriya K, Kurozumi S, Ochs HD.

Int Arch Allergy Immunol. 1996 Jul;110(3):225-32.

PMID:
8688668
38.

Beneficial effects of a novel anti-hypoxemic agent, TEI-7322, on bleomycin-induced experimental hypoxemia in rats.

Horiuchi H, Uejima Y, Sakuma Y, Kadota T, Okada N, Taniguchi K, Takenouchi K, Yamanaka Y, Uno H, Komoriya K.

Eur J Pharmacol. 1995 Dec 4;287(1):27-34.

PMID:
8666022
39.

Suppression of human immunoglobulin E antibody production by a new naphthalene derivative.

Uejima Y, Takahashi K, Komoriya K, Kurozumi S, Ochs HD.

Immunopharmacology. 1995 Aug;30(2):167-76.

PMID:
8530258
41.

Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees.

Komoriya K, Osada Y, Hasegawa M, Horiuchi H, Kondo S, Couch RC, Griffin TB.

Eur J Pharmacol. 1993 Dec 21;250(3):455-60.

PMID:
8112406
42.

Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents.

Osada Y, Tsuchimoto M, Fukushima H, Takahashi K, Kondo S, Hasegawa M, Komoriya K.

Eur J Pharmacol. 1993 Sep 14;241(2-3):183-8.

PMID:
8243554
43.

1,25-Dihydroxyvitamin D3 inhibits thromboxane release from activated macrophages.

Horiuchi H, Nagata I, Takahashi K, Tsuchimoto M, Komoriya K.

Res Commun Chem Pathol Pharmacol. 1992 Nov;78(2):235-43.

PMID:
1475528
44.

Inhibitory effect of activated protein C on platelet aggregation induced by the prothrombin-converting reaction.

Komoriya K, Inoue K, Takahashi K, Suzuki K.

Thromb Res. 1992 Sep 15;67(6):705-10.

PMID:
1440535
45.

Characterization of immunomodulating action of TI-31 on antibody response in mice.

Komoriya K, Nagata I, Takeshita T, Yamamoto I.

J Pharmacobiodyn. 1991 Aug;14(8):443-7.

PMID:
1837801
46.

Protective effect of vitamin D3 analogues on endotoxin shock in mice.

Horiuchi H, Nagata I, Komoriya K.

Agents Actions. 1991 Jul;33(3-4):343-8.

PMID:
1659158
47.

Synthesis of methanoleukotriene A4 analogs and their pharmacological activities.

Hazato A, Kurozumi S, Ohta T, Ohtsu A, Yagyu Y, Komoriya K, Fujiwara H, Mori R.

Adv Prostaglandin Thromboxane Leukot Res. 1989;19:639-42. No abstract available.

PMID:
2546402
48.

Effects of cimetidine on quinidine distribution in rats.

Shibasaki S, Komoriya K, Gon S, Matsuura Y, Nishigaki R, Umemura K.

J Pharmacobiodyn. 1987 Dec;10(12):719-26.

PMID:
3451957
49.

Anti-arthritic and immunoregulatory effects of TI-31 on collagen-induced arthritis.

Komoriya K, Nagata I, Kunisawa K, Takeshita T, Naruchi T.

Jpn J Pharmacol. 1987 Nov;45(3):389-96.

50.

Inhibitory effect of TI-31 on autoimmune nephritis in NZB/NZW F1 mice through regulation of the immune response.

Komoriya K, Nagata I, Tsuchimoto M, Kunisawa K, Koyama T, Hosoda K, Takeshita T, Naruchi T, Yamamoto I, Abe C, et al.

Immunopharmacology. 1987 Apr;13(2):89-98.

PMID:
3496322

Supplemental Content

Loading ...
Support Center